Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alessandro Doria, MD PhD MPH
Joslin Diabetes Center
Principal Investigator - David Cherney, MD PhD
University of Toronto
Principal Investigator - Michael Mauer, MD
University of Minnesota
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Unversity of Calgary
Calgary, Alberta, Canada
Ronald Sigal, MD MPHRecruiting - Alberta Diabetes Institute
Edmonton, Alberta, Canada
Anna Lam, MDPeter Senior, MDRecruiting - St. Paul'S Hospital
Vancouver, British Columbia, Canada
Adeera Levin, MDSean Barbour, MDRecruiting - Lmc Diabetes and Endocrinology
Toronto, Ontario, Canada
Ronnie Aronson, MDRecruiting - Toronto General Hospital
Toronto, Ontario, Canada
Ayodele Odutayo, MDBruce Perkins, MD MPHDavid Cherney, MDHuajing Ni, MDTaewon Yi, MDVikas S. Sridhar, MDRecruiting - Institut de Recherches Cliniques de Montréal
Montreal, Quebec, Canada
Nadine Taleb, MDRemi Rabasa-Lhoret, MDRecruiting
- Stanford University Medical Center
Stanford, California, United States
David Maahs, MDMarina Basina, MDRecruiting - Barbara Davis Center / University of Colorado Denver
Aurora, Colorado, United States
Halis Akturk, MDSarit Polsky, MDRecruiting - Adventhealth
Orlando, Florida, United States
Tina ThethiRecruiting - Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
Amisha Wallia, MDRecruiting - Joslin Diabetes Center
Boston, Massachusetts, United States
Alessandro Doria, MD PhD MPHElena Toschi, MDSylvia Rosas, MDRecruiting - Washington University
St Louis, Missouri, United States
Huda Al-Bahadili, MDJanet McGill, MDKai Jones, MDMaamoun Salam, MDRecruiting - Suny Upstate Medical University
Syracuse, New York, United States
Katherine McPhee, MSN, FNP-C, RNMalek El Muayed, MD, MSCIRuth Weinstock, MDRecruiting - Albert Einstein College of Medicine / Montefiore Medical Center
The Bronx, New York, United States
Jill Crandall, MDJustin Mathew, MDMatthew Abramowitz, MDRecruiting - Cleveland Clinic Foundation
Cleveland, Ohio, United States
Keren Zhou, MDLuiza Caramori, MD PhDRecruiting - Oregon Health and Science University
Portland, Oregon, United States
Andrew Ahmann, MDRodica Busui, MD, PhDRecruiting - University of Texas Southwestern
Dallas, Texas, United States
Amy Shah, MDIldiko Lingvay, MDOksana Hamidi, DORecruiting - University of Washington
Seattle, Washington, United States
Ian de Boer, MDIrl Hirsch, MDKalie Tommerdahl, MDPetter Bjornstad, MDRecruiting - Providence Sacred Heart Medical Center
Spokane, Washington, United States
Katherine R. Tuttle, MDMichael Ryan, MDRadica Alicic, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2024
- Primary completion
- 31 Dec 2028
- Completion
- 31 May 2029
- Last update posted
- 24 Mar 2026
- Registered enrollment
- 150
- Registry id
- NCT06217302
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.